Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sanofi enjoys solid Q1, despite continuing erosion of Lantus sales in U.S.
Sanofi enjoys solid Q1, despite continuing erosion of Lantus sales in U.S.
Sanofi enjoys solid Q1, despite continuing erosion of Lantus sales in U.S.
Submitted by
admin
on April 29, 2017 - 10:07am
Source:
Fierce Pharma
News Tags:
Sanofi
earnings
diabetes
Lantus
Headline:
Sanofi enjoys solid Q1, despite continuing erosion of Lantus sales in U.S.
Do Not Allow Advertisers to Use My Personal information
